Trial intelligence / Profile preview

Endoscopic facial nerve regeneration surgery using bFGF

jRCTs031180379Recruiting

Start
Aug 2015
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Open-label, single-arm trial of trafermin in facial palsy. Primary endpoint: Recovery rate of facial nerve palsy. Started Aug 2015; status: recruiting.

02

Drugs

trafermin
03

Conditions

facial palsy

Beyond the preview

Go deeper on jRCTs031180379.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031180379.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call